Science Explorer Back to mapMap
Institution · Momentum Research

Most cited papers from Momentum Research

What are the most cited papers from Momentum Research?

The most cited paper from Momentum Research is "Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial" (Alexandre Mebazaa, Beth A. Davison, Ovidiu Chioncel et al., 2022), with 1,098 citations. Next come "Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial" (919) and "Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure" (511).

Showing 50 of 60 papers. Every paper with more than 75 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial Alexandre Mebazaa, Beth A. Davison, Ovidiu Chioncel et al. · The Lancet Open access 7 Nov 2022 1,098
2 Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial John R. Teerlink et al. · The Lancet 6 Nov 2012 919
3 Rolofylline, an Adenosine A1−Receptor Antagonist, in Acute Heart Failure Barry M. Massie, Christopher M. O’Connor, Marco Metra et al. · New England Journal of Medicine Open access 6 Oct 2010 511
4 Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure? Marco Metra, Beth A. Davison, Luca Bettari et al. · Circulation Heart Failure 14 Dec 2011 491
5 Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials Beth A. Davison, Stephen A. Harrison, Gad Cotter et al. · Journal of Hepatology 28 Jun 2020 449
6 Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Marco Metra et al. · Journal of the American College of Cardiology Open access 26 Dec 2012 432
7 Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study John R. Teerlink, Marco Metra, Gary Michael Felker et al. · The Lancet 30 Mar 2009 425
8 Worsening Renal Function in Patients Hospitalised for Acute Heart Failure: Clinical Implications and Prognostic Significance Marco Metra, Savina Nodari, Giovanni Parrinello et al. · European Journal of Heart Failure Open access Feb 2008 380
9 Diuretic response in acute heart failure: clinical characteristics and prognostic significance Mattia A. E. Valente, A.A. Voors, Kevin Damman et al. · European Heart Journal 28 Feb 2014 367
10 Fluid Overload in Acute Heart Failure — Re-Distribution and Other Mechanisms Beyond Fluid Accumulation Gad Cotter, Marco Metra, Olga Milo‐Cotter et al. · European Journal of Heart Failure Feb 2008 328
11 Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure Jorge Rubio‐Gracia, Biniyam G. Demissei, Jozine M. ter Maaten et al. · International Journal of Cardiology Open access 13 Mar 2018 305
12 Effects of Serelaxin in Patients with Acute Heart Failure Marco Metra et al. · New England Journal of Medicine Open access 21 Aug 2019 278
13 The role of the kidney in heart failure Marco Metra, Gad Cotter, Mihai Gheorghiade et al. · European Heart Journal 10 Aug 2012 261
14 Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study Stephen A. Harrison, Naim Alkhouri, Beth A. Davison et al. · Journal of Hepatology 4 Nov 2019 213
15 Inflammatory activation: cardiac, renal, and cardio-renal interactions in patients with the cardiorenal syndrome P.C. Colombo, Anjali Ganda, Jeffrey Lin et al. · Heart Failure Reviews Open access 18 Jun 2011 211
16 Signature of Circulating microRNAs in Patients with Acute Heart Failure Ekaterina S. Ovchinnikova et al. · European Journal of Heart Failure Open access 8 Sep 2015 206
17 Cardiopoietic cell therapy for advanced ischemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial Jozef Bartúnek et al. · European Heart Journal Open access 18 Oct 2016 186
18 The Predictive Value of Short-Term Changes in Hemoglobin Concentration in Patients Presenting With Acute Decompensated Heart Failure Peter van der Meer, Douwe Postmus, Piotr P. Ponikowski et al. · Journal of the American College of Cardiology Open access 14 Mar 2013 178
19 Increased Blood Lactate is Prevalent and Identifies Poor Prognosis in Patients with Acute Heart Failure without Overt Peripheral Hypoperfusion Robert Zymliński, Jan Biegus, Mateusz Sokolski et al. · European Journal of Heart Failure Open access 12 Feb 2018 175
20 The PROTECT Pilot Study: A Randomized, Placebo-Controlled, Dose-Finding Study of the Adenosine A1 Receptor Antagonist Rolofylline in Patients With Acute Heart Failure and Renal Impairment Gad Cotter, Howard C. Dittrich, Beth A. Davison et al. · Journal of Cardiac Failure 16 Sep 2008 174
21 Diuretic Response in Patients with Acute Decompensated Heart Failure: Characteristics and Clinical Outcome—an Analysis from RELAX-AHF Adriaan A. Voors, Beth A. Davison, John R. Teerlink et al. · European Journal of Heart Failure Open access 7 Oct 2014 154
22 Biased ligand of the angiotensin II type 1 receptor in patients with acute heart failure: a randomized, double-blind, placebo-controlled, phase IIB, dose ranging trial (BLAST-AHF) Peter S. Pang, Javed Butler, Sean P. Collins et al. · European Heart Journal Open access 25 Mar 2017 152
23 Relaxin: Review of Biology and Potential Role in Treating Heart Failure Sam L. Teichman, Elaine Unemori, John R. Teerlink et al. · Current Heart Failure Reports Open access 27 Apr 2010 142
24 Serial High Sensitivity Cardiac Troponin T Measurement in Acute Heart Failure: Insights from the Relax-Ahf Study Gary Michael Felker, Robert John Mentz, John R. Teerlink et al. · European Journal of Heart Failure Open access 3 Sep 2015 138
25 Effects of the Adenosine A1 Receptor Antagonist Rolofylline on Renal Function in Patients With Acute Heart Failure and Renal Dysfunction Adriaan A. Voors, Howard C. Dittrich, Barry M. Massie et al. · Journal of the American College of Cardiology Open access May 2011 133
26 Elements of Wireless Power Transfer Essential to High Power Charging of Heavy Duty Vehicles John M. Miller, Andrew Daga · IEEE Transactions on Transportation Electrification 7 May 2015 133
27 Predictors of Postdischarge Outcomes From Information Acquired Shortly After Admission for Acute Heart Failure John G.F. Cleland, Karen Chiswell, John R. Teerlink et al. · Circulation Heart Failure Open access 27 Nov 2013 124
28 A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure Piotr P. Ponikowski, Veselin L. Mitrović, Mikhail Ruda et al. · European Heart Journal Open access 18 Nov 2013 124
29 An alternating projection that does not converge in norm Hein S. Hundal · Nonlinear Analysis 12 Mar 2004 124
30 Serelaxin in Addition to Standard Therapy in Acute Heart Failure: Rationale and Design of the RELAX-AHF-2 Study John R. Teerlink, Adriaan A. Voors, Piotr P. Ponikowski et al. · European Journal of Heart Failure Open access 28 Apr 2017 123
31 Readmission and death after an acute heart failure event: predictors and outcomes in sub-Saharan Africa: results from the THESUS-HF registry Karen S Sliwa, Beth A. Davison, Bongani M. Mayosi et al. · European Heart Journal Open access 18 Sep 2013 122
32 Relaxin, a pleiotropic vasodilator for the treatment of heart failure Sam L. Teichman, Elaine Unemori, Thomas Bernd Dschietzig et al. · Heart Failure Reviews Open access 19 Dec 2008 122
33 Assessing Parenting Skills and Attitudes: A Review of the Psychometrics of Parenting Measures Kristin Duppong Hurley, Jacqueline N. Huscroft-D’Angelo, Alexandra L. Trout et al. · Journal of Child and Family Studies 26 Feb 2013 122
34 Serial Assessment of Spot Urine Sodium Predicts Effectiveness of Decongestion and Outcome in Patients with Acute Heart Failure Jan Biegus, Robert Zymliński, Mateusz Sokolski et al. · European Journal of Heart Failure Open access 17 Feb 2019 121
35 Benefit of Cardiopoietic Mesenchymal Stem Cell Therapy on Left Ventricular Remodelling: Results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) Study John R. Teerlink, Marco Metra, Gerasimos S Filippatos et al. · European Journal of Heart Failure Open access 31 May 2017 121
36 The PROTECT In-Hospital Risk Model: 7-Day Outcome in Patients Hospitalized with Acute Heart Failure and Renal Dysfunction Christopher M. O’Connor, Robert John Mentz, Gad Cotter et al. · European Journal of Heart Failure Open access 25 Apr 2012 120
37 Early Drop in Systolic Blood Pressure and Worsening Renal Function in Acute Heart Failure: Renal Results of Pre-RELAX-AHF Adriaan A. Voors, Beth A. Davison, Gary Michael Felker et al. · European Journal of Heart Failure Open access 28 May 2011 118
38 Biomarker Profiles of Acute Heart Failure Patients With a Mid-Range Ejection Fraction Jasper Tromp, Mohsin A.F. Khan, Robert John Mentz et al. · JACC Heart Failure Open access 15 Jun 2017 116
39 Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure Yuya Matsue, Peter van der Meer, Kevin Damman et al. · Heart 22 Sep 2016 115
40 Growth Differentiation Factor 15 (GDF-15) in Patients Admitted for Acute Heart Failure: Results from the RELAX-AHF Study Gad Cotter, Adriaan A. Voors, MARGARET FORNEY PRESCOTT et al. · European Journal of Heart Failure Open access 3 Sep 2015 114
41 A Multimarker Multi-Time Point-Based Risk Stratification Strategy in Acute Heart Failure: Results from the RELAX-AHF Trial Biniyam G. Demissei, Gad Cotter, MARGARET FORNEY PRESCOTT et al. · European Journal of Heart Failure Open access 30 Jan 2017 110
42 Abnormal Liver Function Tests in Acute Heart Failure: Relationship with Clinical Characteristics and Outcome in the PROTECT Study Jan Biegus, Hans L. Hillege, Douwe Postmus et al. · European Journal of Heart Failure 12 May 2016 107
43 Serelaxin in acute heart failure patients with preserved left ventricular ejection fraction: results from the RELAX-AHF trial Gerasimos Filippatos, J. R. Teerlink, Dimitrios T. Farmakis et al. · European Heart Journal Open access 6 Dec 2013 105
44 Calls to Police and Police Response: A Case Study of Latina Immigrant Women in the USA Nawal H. Ammar, Leslye E. Orloff, Mary Ann Dutton et al. · International Journal of Police Science & Management Dec 2005 103
45 Dyspnoea and Worsening Heart Failure in Patients with Acute Heart Failure: Results from the Pre-RELAX-AHF Study Marco Metra, John R. Teerlink, Gary Michael Felker et al. · European Journal of Heart Failure Open access 23 Aug 2010 101
46 Employee Satisfaction and Theft: Testing Climate Perceptions as a Mediator John Kulas, Joanne McInnerney, Rachel Frautschy DeMuth et al. · The Journal of Psychology Jul 2007 99
47 Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond John R. Teerlink, Marco Metra, Valerio Zacà et al. · Heart Failure Reviews Open access 29 Oct 2009 96
48 Early dyspnoea relief in acute heart failure: prevalence, association with mortality, and effect of rolofylline in the PROTECT Study Marco Metra, Cathal O’Connor, Beth A. Davison et al. · European Heart Journal Open access 8 Mar 2011 93
49 Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart Failure Christopher M. O’Connor, Mona Fiuzat, Carlo Mario Lombardi et al. · Circulation Heart Failure Open access 7 Sep 2011 91
50 ECGScan: a method for conversion of paper electrocardiographic printouts to digital electrocardiographic files Fabio Badilini, A. Tanju Erdem, Wojciech Zaręba et al. · Journal of Electrocardiology Oct 2005 90

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.